Accessibility Menu
Hypha Labs logo

Hypha Labs(OTC) DIGP

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-100%
5 Year-81%
1 Year-67%
1 Month-52%
N/A
Hypha Labs last closing stock price
MetricPriceDate
Last closeUSD 0.012026-08-27
Hypha Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.63%USD 0.012026-08-20
1 month-51.87%USD 0.022026-07-24
3 month-28.8%USD 0.012026-05-29
Year to date-77.5%USD 0.042025-12-31
1 year-66.6%USD 0.032025-08-27
3 year-40.4%USD 0.022023-08-28
5 year-81.4%USD 0.052021-08-27
Since inception-99.91%USD 10.102012-06-20

Hypha Labs Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.91M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

DIGP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hypha Labs

Hypha Labs makes a home device for growing edible mushrooms quickly. The product helps people add functional mushrooms to food without complex steps. It is designed for consumers who want easy, at-home mushroom production.

Fungi at Your Fingertips: Products and Services

  • Hypha Micropearl accelerator: Home appliance for producing edible mushroom mycelium in eight days; 0% of revenue as of June 30, 2025.
  • Replacement cartridges: Pre-sterilized, nutrient-filled cartridges for the device; 0% of revenue as of June 30, 2025.
  • Mobile app integration: App for device management and tracking; supports home users.
  • Discontinued cannabis testing: Former lab testing services for cannabis and hemp; 100% of revenue in 2024, now discontinued.

Spore to Store: Growth and Expansion Moves

  • Sold cannabis testing business in February 2024 to focus on mushroom appliance.
  • Developed Hypha Micropearl accelerator through subsidiary Hypha Products Inc. in 2024-2025.
  • Planned manufacturing partnerships outside the U.S. in 2025.
  • Issued new stock options and warrants to consultants and directors in 2025.
  • Exploring future investments and possible acquisitions as of 2025.

Why Hypha Labs Stands Out in the Crowd

Hypha Labs targets home users with a device and cartridge system that reduces contamination risk. The company integrates its product with a mobile app for easier management. Its shift from cannabis testing to consumer biotech appliances marks a major strategic change.

Five Things You Need to Know

  • Revenue was $0 in QQ4 2025, unchanged from QQ4 2024.
  • Net loss was $490,955 in QQ4 2025, down 2,473.4% from QQ4 2024.
  • Cash used in operations was $64,912 for nine months ended June 2025.
  • Negative working capital was $1,846,324 as of June 30, 2025.
  • Five full-time employees as of June 2025; no commercial sales yet.

Bottom Line

Hypha Labs has shifted from cannabis testing to developing a home mushroom appliance. The company is pre-revenue and faces significant financial challenges as it seeks to commercialize its new product.

AI Generated • Apr 16, 2026

Industry

Household Durables

Sector

Consumer Discretionary

Employees

5

CEO

Angus Stone Douglass

Website

hyphalabs.com

Headquarters

Las Vegas, NV 89118, US

DIGP Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

73.84%

Return on Capital

N/A

Return on Assets

-2789.42%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$558.06K

EBITDA

$607.64K

Operating Cash Flow

-$568.06K

Capital Expenditure

-$31.24K

Free Cash Flow

-$599.29K

Cash & ST Invst.

$5.11K

Total Debt

$1.79M

Hypha Labs Performance Analysis

Hypha Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 0N/A
20232023-09-30USD 0N/A
20242024-09-30USD 0N/A
20252025-09-30USD 0N/A
Hypha Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30N/A
Q12025-12-31N/A
Q22026-03-31N/A
Q32026-06-30N/A
Hypha Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD -0.03191.3%
20232023-09-30USD 0.00N/A
20242024-09-30USD -0.01N/A
20252025-09-30USD -0.02194.9%
Hypha Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30100.0%
Q12025-12-31N/A
Q22026-03-312.9%
Q32026-06-3042.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

17

N/A

Net Income

-$304.76K

+45.8%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$5.11K

-96.5%

Total Debt

$1.79M

+18.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.56M

N/A

Short Term Debt

$231.89K

-84.7%

Return on Assets

-27.89%

N/A

Return on Invested Capital

97.25%

N/A

Free Cash Flow

-$52.09K

-123.6%

Operating Cash Flow

-$52.09K

-123.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NOVCNovation Companies, Inc.
$0.01+316.67%
ETRGFEntourage Health Corp.
$0.00+14.29%
GNOWAmerican Caresource Holdings, Inc.
$0.00+0.00%
PCNTPoint of Care Nano-Technology, Inc.
$0.01-90.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About DIGP

What is the current price of Hypha Labs?

Hypha Labs is trading at N/A per share.

What is the 52-week range for Hypha Labs?

Over the past 52 weeks, Hypha Labs has traded between N/A and N/A.

How much debt does Hypha Labs have?

As of the most recent reporting period, Hypha Labs reported total debt of $1.79M.

How much cash does Hypha Labs have on hand?

Hypha Labs reported $5.11K in cash and cash equivalents in its most recent financial results.

What is Hypha Labs’s dividend yield?

Hypha Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services